Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
INNOVATIVE REARING AND STUNNING OF FARMED TURBOT AND SOLE TO MEET FUTURE CHALLENGES REGARDING QUALITY OF PRODUCTION AND ANIMAL WELFARE (MAXIMUS)

Framework: FP7 — Capacities
Programme: Research for the benefit of SMEs
Destination: Research for SMEs
Action type: Research for the benefit of specific groups
Countries involved: Norway,Netherlands,Iceland,Netherlands,Spain,United Kingdom,Portugal,Spain,Spain
Call:  (FP7-SME-2011, 2011)
Start date: 2012-01-01
End date: 2014-06-30
Duration (months): 30.0
Total project cost (EUR): 1804824.0
EU funding (EUR): 1365784.0
Participants: 15
Project status: CLOSED

Turbot (Scophthalmus maximus) is identified as one of the most promising candidates for marine aquaculture in Europe, with several characteristics that make it an interesting species for commercial growers and European consumers. The species has tremendous potential as an aquaculture species but many of its attributes are currently unexploited utilize. European production of turbot has been increasing during the last 20 years from about 100 to over 11000 metric tons. However, in order to expand the production beyond this level, new bio- and technological solutions are urgently needed. The biological and technological focus in the present project will be on improving the rearing environment, optimized slaughter methods and improved fish welfare and quality of the produced products. We also include a comprehensive assessment of the economic ramifications of the proposed optimized rearing. These measures are all aimed at improving productivity of the turbot farms leading to more cost effective production and better use of the resources involved. By addressing the whole value chain it is foreseen that the current proposal may lay the foundation for more cost-effective production of turbot in Europe. The approach of the project is multidisciplinary where the Project Consortium will work with those scientific and practical problems considered most important for future sustainable expansion by the SME proposers. This project brings together a balanced and integrated consortium of fish farmers and scientists, with wide project experience, in a number of interrelated disciplines; growth physiology, immunology/health, welfare, slaughter methods, quality aspects and fish economics; all concentrating on improving the culture of turbot. To increase the general applicability of the MAXIMUS proposal, the innovative slaughter methods will also be tested for sole (Solea solea, S. senegalensis). Sole is a promising European aquaculture species, cultured side-by-side with turbot facing similar technological challenges.

Keywords: biological optimization,new slaughter methods,fish welfare,economics,turbot,sole,aquaculture
The integration of intermediate pyrolysis and vapour gasification to create and effective and efficient biomass-to-energy system for combined heat and power. (PYROGAS)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Industry-Academia Partnerships and Pathways
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: United Kingdom,Germany,Germany
Call:  (FP7-PEOPLE-2011-IAPP, 2011)
Start date: 2012-04-01
End date: 2016-03-31
Duration (months): 48.0
Total project cost (EUR): 1082575.0
EU funding (EUR): 1082575.0
Participants: 3
Project status: CLOSED

The use of biomass, and waste, as a fuel for the production of energy in the form of electrical power and heat has in recent years come to be recognised as a key element in the move to sustainable forms of energy as part of the strategy to combat climate change. Throughout Europe, challenging targets for the provision of bioenergy and reduction in carbon emissions have been identified but progress towards those targets is extremely slow. Thus, to enable a concerted, informed, and joint development this project brings together a leading European Bioenergy Research institute (EBRI) that has new key patents in the clean and efficient thermal treatment of biomass based on the Intermediate Pyrolysis process, with two European SME companies recognised for their respective technical and engineering expertise in the provision of thermal treatment plant (WGD) and gasifier technology (WWAG) respectively. A Demonstration installation has recently been approved for funding at EBRI which not only gives significant added value (€15M) in terms of the stand alone technology installations but, more importantly, provides a unique opportunity to integrate the pyrolysis and gasification processes to produce a cost efficient flexible,optimised, linear process for power and heat production from biomass and waste. The aim of the programme is therefore, through a programme of laboratory and demonstration scale testing, to fully integrate the intermediate pyrolysis and gasification processes to form the PYROGAS concept for power and heat from biomass, and to demonstrate its successful operation on a range of feedstocks.

Keywords: pyrolysis,gasification,engine,biomass,bioenergy,heat,power,chp,cogeneration,thermochemical conversion,wastes
Heart and respiration in-car embedded nonintrusive sensors (HARKEN)

Framework: FP7 — Capacities
Programme: Research for the benefit of SMEs
Destination: Research for SMEs
Action type: Research for the benefit of specific groups
Countries involved: Portugal,Spain,Estonia,United Kingdom,Portugal,Spain,Germany
Call:  (FP7-SME-2011, 2011)
Start date: 2012-06-01
End date: 2014-05-31
Duration (months): 24.0
Total project cost (EUR): 1360045.2
EU funding (EUR): 1053061.0
Participants: 8
Project status: CLOSED

Road accidents are a major safety problem in developed countries, and fatigue is one of the critical factors. In-vehicle fatigue detectors can reduce this problem, saving 4,000 lives and preventing tens of thousand injuries every year in the EU, which in economical terms would imply annual savings of €7 Billion. For this reason, automotive OEM and TIER 1 are striving to achieve good solutions for automatic fatigue detection, but current approaches have strong limitations, because they lack the direct information about drivers’ physiological variables, which are critical for a successful evaluation of their state. This project gathers a consortium of SMEs that produce vehicle components (seat cover textiles and safety belts), smart materials, and sensors for biomonitoring, who will create a product to address that need. They will join their experience to create a nonintrusive sensor system of heart and respiration with smart materials, embedded in the seat cover and the safety belt of a car. This device will detect the effect of heart and respiration activity, filter and cancel the noise and artefacts expected in a moving vehicle, and calculate the relevant parameters, which will be delivered in a readable format to integrate it in a fatigue detector. The achievement of this objective will require to perform a research to develop new sensing materials, and create a signal processing unit to filter and process the data. This project will provide the SMEs with new, high technology products to sell in their sectors, and will help them to enter or improve their position in the automotive market, with a new device that will enable the creation of reliable fatigue detectors.

Keywords: sensors,smart materials,heart rate,respiration,signal noise filtering
FOrecast and Roadmapping for MAnufacturing Technologies (FORMAT)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Industry-Academia Partnerships and Pathways
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: Italy,Italy,Poland,Belgium,France
Call:  (FP7-PEOPLE-2011-IAPP, 2011)
Start date: 2012-01-01
End date: 2015-12-31
Duration (months): 48.0
Total project cost (EUR): 1690454.0
EU funding (EUR): 1690454.0
Participants: 6
Project status: CLOSED

The analysis of emerging technologies and their potential impact on markets, economies and societies requires reliable and repeatable methods and tools since the related information plays a critical role for strategic decisions of private and public organizations. All existing techniques reveal several weaknesses such as limited accuracy on middle and long-term forecast; poor repeatability; poor adaptability, i.e. no universal methods are known, besides complementary instruments must be integrated according to the specific goal and data availability. These considerations highlight the need to introduce structured methods and tools capable to support strategic decisions in industrial R&D activities, by managing the multi-disciplinary complexity of current systems and by anticipating the future characteristics of products and processes. The final FORMAT project result will be the development of an innovative forecasting methodology, backed by a web semantic IT tool, supporting decision making in Manufacturing Industries, to be evaluated in real test cases and extensively described in the FORMAT handbook and through an IT demonstrator to proof the concept.

Keywords: technological sciences,process engineering,speech processing,software technology
DNA-based tests for commercial medicinal plant authentication. (VITANGO)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Industry-Academia Partnerships and Pathways
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: United Kingdom,Germany
Call:  (FP7-PEOPLE-2011-IAPP, 2011)
Start date: 2012-03-01
End date: 2016-02-29
Duration (months): 48.0
Total project cost (EUR): 449391.0
EU funding (EUR): 449391.0
Participants: 2
Project status: CLOSED

The unambiguous identification of plant raw material is a crucial step in the quality control of medicinal plants in order to guarantee the identity and a constant and reliable quality of the starting material. Apart from the classical pharmacognostic methods, phytochemical methods (often based on chromatography) are used for this purpose. However, these methods often fail to provide secure results, especially when only single plant parts are available, and therefore, there is a need for novel and more reliable methods. DNA-based identification methods are becoming increasingly relevant in this respect and have much potential to be powerful additions to the classical techniques. Using the medicinal plant Rhodiola rosea as an example, this project has the following objectives: a. To develop a sensitive, quantitative DNA-based test to distinguish Rhodiola rosea plant material from related plant species, and to detect low level contamination by these potential adulterants b. To introduce the DNA test for Rhodiola authentication into the QC procedures of the commercial partner c. To develop phytochemical and pharmacognostic methods to detect low level contamination of Rhodiola rosea plant material by potential adulterant plant species d. To determine the feasibility of incorporating DNA-based tests for a range of plants into the industrial partner’s quality control procedures. e. To identify the most appropriate strategy and technology platform for DNA-based tests for recommendation as an industry standard for regulation and quality assurance. These objectives will be acheived by a synergistic partnership between a university molecular biologicial research group and a phytopharmaceutical company, designed to fully exploit the opportunities for secondment and training provided by this scheme.

Keywords: systematic botany,pharmacognosy,industrial crop products,horticulture,plant genetics,molecular markers and recognition
Wireless Friendly Energy Efficient Buildings (WIFEEB)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Industry-Academia Partnerships and Pathways
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: United Kingdom,Czechia,United Kingdom
Call:  (FP7-PEOPLE-2011-IAPP, 2011)
Start date: 2012-01-01
End date: 2015-12-31
Duration (months): 48.0
Total project cost (EUR): 2145330.0
EU funding (EUR): 2145330.0
Participants: 3
Project status: CLOSED

The wireless performance of building design is not understood and the construction industries do not consider wireless system performance in their designs or specifications despite the rapid employment of metal skins and windows and facades containing metallised layers for energy conservation, both of which are a significant problem for wireless signal propagation. Hence there is a significant need to understand the performance of buildings and construction materials for efficient energy consumption and for the efficient propagation of radio waves. This project’s objectives are to develop and verify the new concept of the wireless friendly, energy efficient building. The wireless propagation properties of building and insulation materials must be assessed. The same properties must be measured for building structures such as walls (internal and external), floors, facades and window systems. These properties will be evaluated from 400 MHz to 20 GHz to include both current and future wireless networks and systems. A significant part of this project is the development and optimisation of CAD tools that combine wireless propagation models with energy efficiency models producing a complete model for the built environment. New innovative construction materials such as glass and steel fibre reinforcement will be studied and new architectural designs investigated to improve wireless signal propagation while maintaining energy efficiency. The project will address how existing buildings can be reconfigured in addition to showing how new buildings can be designed for wireless and energy efficiency. Several case studies will be modelled including a secure building, a smart home including smart energy metering, the use of intelligent reconfigurable structures and a mixed use shopping/commercial environment. Finally four test projects will evaluate energy and wireless buildings experimentally.

Keywords: concrete engineering,building design,environmental design,energy-efficient building designs,wireless systems,building construction
Exploitation of microalgae diversity for the development of novel high added-value cosmeceuticals (ALGAECOM)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Industry-Academia Partnerships and Pathways
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: Greece,France,Spain
Call:  (FP7-PEOPLE-2011-IAPP, 2011)
Start date: 2011-10-01
End date: 2015-09-30
Duration (months): 48.0
Total project cost (EUR): 1570928.0
EU funding (EUR): 1570928.0
Participants: 4
Project status: CLOSED

Microalgae have the potential to revolutionize biotechnology in a number of areas including nutrition, aquaculture, pharmaceuticals, cosmeceuticals and biofuels. AlgaeCom project seeks to exploit the microalgae biodiversity, as a source for state-of-the-art high-added-value cosmeceuticals. The project will combine both basic and applied research in the fields of –omics technologies, biochemistry and applied biotechnology in order to, a) Develop catalomics, metabolomics and glycomics resources for microalgae diversity as a valuable source of novel high-added-value cosmeceuticals such as polysaccharides, enzymes and secondary metabolites; b) In vitro functional characterize and toxicologicaly analyse microalgae cosmeceuticals using human epidermal cell lines and in vitro skin model; c) Develop and optimize application-based microalgae culture systems at different scales and optimize culture conditions for higher production rate of desired products; d) Develop analytical molecular diagnostic tools for real-time monitoring of the microalgae carbohydrate and polysaccharide metabolism in large scale cultures; e) Develop, formulate and in vitro evaluate cosmetic products based on microalgae cosmeceuticals (enzymes, small secondary metabolites and polysaccharides). The AlgaeCom project will offer the opportunity for the development of well defined end products (cosmetic products, RT-qPCR molecular tools) to industrial partners. Finally, the integration of advanced research with an efficient mechanism for transfer of knowledge, training and dissemination will contribute favourably to the reinforcement of the collaboration between academia and industry.

Keywords: cosmetology,marine biotechnology,biotechnology,biochemical technology
Adsorbent carbons for the removal of biologically active toxins (ACROBAT)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Industry-Academia Partnerships and Pathways
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: United Kingdom,Ukraine,United Kingdom,United Kingdom,Germany,Germany
Call:  (FP7-PEOPLE-2011-IAPP, 2011)
Start date: 2012-12-01
End date: 2016-11-30
Duration (months): 48.0
Total project cost (EUR): 1449659.0
EU funding (EUR): 1449659.0
Participants: 7
Project status: CLOSED

The aim of the project is to manufacture an adsorbent carbon based cartridge within a perfusion system for the removal of strongly, protein bound and macromolecular toxins and inflammatory molecules including hepatic and uremic toxins, exotoxin, endotoxin and cytokines. These molecules are responsible for systemic toxicity effects and their removal is negligible or unsustained in current systems available for the treatment of renal, hepatic and multiple organ failure (MOF) related to sepsis. Additionally, removal of these molecules during perfusion of organs for transplant will moderate the inflammatory stress response which currently limits the success of marginal organs. The project considers economical and environmental impact in the development of processing strategies which optimise the adsorptive, biocompatible and hydrodynamic design properties of the resultant system for these applications. The project brings together a multidisciplinary consortium of specialists with many years experience in the development, analysis and clinical implementation of adsorbent biomaterials in extracorporeal systems and in the development of transplant organ preservation techniques.

Keywords: nanobiotechnology,biomedical materials
Biomarker Applications for Nanotechnology and Imaging in Diabetes (UROSENSE)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Industry-Academia Partnerships and Pathways
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: Ireland,Finland,Luxembourg,Sweden,Italy,China
Call:  (FP7-PEOPLE-2011-IAPP, 2011)
Start date: 2012-01-01
End date: 2015-12-31
Duration (months): 48.0
Total project cost (EUR): 2482306.0
EU funding (EUR): 2482306.0
Participants: 6
Project status: CLOSED

UroSense is a focussed research programme to generate new concepts from knowledge creation to knowledge transfer between innovative academic and dedicated industry partners utilising a systematic intersectoral secondment programme. The programme brings leading edge academic European LifeScience capacities of Diabetes research at Dublin City University, Ireland, together with the high-profile protein research center of University of Luxembourg to establish innovative biomarker utilisation. The nano-biotechnologies developed with established life science applications of Tethis S.p.A of Milano, Italy will be the SME partner to translate findings to microfluidic applications while GE Medical System of Sweden will integrate results to the recently established, robust molecular imaging technologies leading to novel diagnostics for the benefit of the diabetes patient. The Chinese partner is a leading biotech company in Guangzhou who will provide not only validation of results but also to develop access to the fastest growing global healthcare market benefiting both academic and industrial partners. All European partners are unequivocally in the leading edge in their own sectors sharing the vision of true impacts achieved with a new collaborative working model including efficient knowledge transfer and a shared clear scientific focus. Our consortium is particularly well balanced, focussed and well resourced to cover the value chain from discovery research to applications utilising novel intersectoral collaborations to expedite the utilisation process.

Keywords: diabetes,microflow,molecular imaging,training network
NEUROACT: A collaborative training program to develop multi-electrode array (MEA) platforms to understand synaptic function and treat diseases of the nervous system (NEUROACT)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Industry-Academia Partnerships and Pathways
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: United Kingdom,Belgium,Switzerland
Call:  (FP7-PEOPLE-2011-IAPP, 2011)
Start date: 2012-10-01
End date: 2016-09-30
Duration (months): 48.0
Total project cost (EUR): 1979673.0
EU funding (EUR): 1979673.0
Participants: 3
Project status: CLOSED

This project proposes unique research training opportunities by bringing together partners with complementary expertise in engineering, electrophysiology, molecular biology, cellular neuroscience, theoretical neuroscience, and advanced data analysis. Trainees will participate in the design and implementation of novel tools and platforms to advance current understanding of the molecular and microcircuit bases for nervous system function and to develop new drug screening platforms and paradigms for diseases of the nervous system. The platform for electrophysiological studies will use multielectrode array (MEA) substrates, for which unique recording and analysis methods and cellular model systems will be developed. This collaborative endeavor brings together three active and highly talented partners who have proven themselves as rising leaders in their respective research fields. The exchanges between the Belgian academic group and Ayanda will afford research, development and training in advanced data analysis techniques, recording and analysis software, and novel materials for chronic neuron-interfacing electrodes. Collaboration between the academic team at the EPF Lausanne and Ayanda will yield new research and training opportunities to advance bioarray designs, improve their molecular application and detection capabilities, and establish rapid user-friendly protocols allowing the implementation of MEA-based systems to study the roles of individual genes on complex synaptic phenotypes. The mutually beneficial diversity and complementarities of the skills brought together in this collaborative project bodes a successful, productive and long-lasting relationship between its partners and trainees. Importantly, this joint venture addresses important unfulfilled needs for basic science and drug discovery in neurobiology with far-reaching potential benefits to both European industry and health research.

Keywords: neurodegeneration,nervous system disorders,electrophysiology,multielectrode arrays,huntington's disease,parkinson's disease,alzheimer's disease,drug screening,computational neuroscience